医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
10期
1892-1895
,共4页
贺兼斌%向志%易高众%张平
賀兼斌%嚮誌%易高衆%張平
하겸빈%향지%역고음%장평
黄芪%皂苷类/药理学%肺纤维化/代谢%蛋白激酶类%糖皮质激素类/分析%大鼠, Sprague-Dawley
黃芪%皂苷類/藥理學%肺纖維化/代謝%蛋白激酶類%糖皮質激素類/分析%大鼠, Sprague-Dawley
황기%조감류/약이학%폐섬유화/대사%단백격매류%당피질격소류/분석%대서, Sprague-Dawley
Astragalus membranaceus%Saponins/PD%Pulmonary Fibrosis/ME%Protein Kinases%Glucocorticoids/AN%Rats,Sprague-Dawley
【目的】研究黄芪甲苷对肺纤维化(PF )大鼠的治疗作用及对肺组织中血清和糖皮质激素调节蛋白激酶1(SGK1)表达的影响。【方法】36只SD大鼠,随机分为对照组、模型组和黄芪甲苷干预组。模型组和干预组气管内注射博来霉素(BLM ,5 mg/kg)诱导PF ,对照组在相同条件下给予生理盐水。干预组大鼠d2开始每天经胃管灌服0.1 g/L黄芪甲苷2 m L ,其余两组相同条件下给予生理盐水。治疗的d7和d28处死动物取出肺组织,进行病理学观察;用免疫组化和RT‐PCR检测各组鼠肺组织SGK1蛋白及mRNA表达的水平。【结果】病理学观察显示:与模型组比较,干预组肺泡炎和纤维化程度均减轻,SGK1蛋白及mRNA表达显著降低;与对照组比较,干预组存在一定程度肺泡炎和纤维化,SGK1蛋白及mRNA表达明显高于对照组。【结论】黄芪甲苷可能通过抑制SGK1的过度表达,对实验性大鼠PF具有良好的治疗作用。
【目的】研究黃芪甲苷對肺纖維化(PF )大鼠的治療作用及對肺組織中血清和糖皮質激素調節蛋白激酶1(SGK1)錶達的影響。【方法】36隻SD大鼠,隨機分為對照組、模型組和黃芪甲苷榦預組。模型組和榦預組氣管內註射博來黴素(BLM ,5 mg/kg)誘導PF ,對照組在相同條件下給予生理鹽水。榦預組大鼠d2開始每天經胃管灌服0.1 g/L黃芪甲苷2 m L ,其餘兩組相同條件下給予生理鹽水。治療的d7和d28處死動物取齣肺組織,進行病理學觀察;用免疫組化和RT‐PCR檢測各組鼠肺組織SGK1蛋白及mRNA錶達的水平。【結果】病理學觀察顯示:與模型組比較,榦預組肺泡炎和纖維化程度均減輕,SGK1蛋白及mRNA錶達顯著降低;與對照組比較,榦預組存在一定程度肺泡炎和纖維化,SGK1蛋白及mRNA錶達明顯高于對照組。【結論】黃芪甲苷可能通過抑製SGK1的過度錶達,對實驗性大鼠PF具有良好的治療作用。
【목적】연구황기갑감대폐섬유화(PF )대서적치료작용급대폐조직중혈청화당피질격소조절단백격매1(SGK1)표체적영향。【방법】36지SD대서,수궤분위대조조、모형조화황기갑감간예조。모형조화간예조기관내주사박래매소(BLM ,5 mg/kg)유도PF ,대조조재상동조건하급여생리염수。간예조대서d2개시매천경위관관복0.1 g/L황기갑감2 m L ,기여량조상동조건하급여생리염수。치료적d7화d28처사동물취출폐조직,진행병이학관찰;용면역조화화RT‐PCR검측각조서폐조직SGK1단백급mRNA표체적수평。【결과】병이학관찰현시:여모형조비교,간예조폐포염화섬유화정도균감경,SGK1단백급mRNA표체현저강저;여대조조비교,간예조존재일정정도폐포염화섬유화,SGK1단백급mRNA표체명현고우대조조。【결론】황기갑감가능통과억제SGK1적과도표체,대실험성대서PF구유량호적치료작용。
[Objective] To explore the efficacy of Astragaloside for the treatment of pulmonary fibrosis (PF) in rats and its influence on the expression of serum and glucocorticoid regulated proteinkinase 1(SGK1) .[Methods] A total of 36 male SD rats were randomly divided into control group ,model group and Astragalo‐side intervention group .The model group and treatment group were induced to produce PF by endotracheal in‐jection of bleomycin ,while the control group was given normal saline in the same condition .From the second day ,the rats in intervention group were intragastric infusion with 0 .1g/L Astragaloside 2ml ,while the rats in other two groups were given normal saline in the same condition .The rats were sacrificed at d7 and d28 of treatment ,and lung tissues were collected for pathological observation .Immunohistochemical method and RT‐PCR were used to detect the expression levels of serum and SGK 1 in lung tissue of rats of each group .[Re‐sults] Pathological examination showed that the degree of alveolitis and pulmonary fibrosis in intervention group was significantly reduced in comparison with the model group ,and the expressions of serum and SGK1 in intervention group were obviously higher than those in control group .[Conclusion] Astragalaside may have good efficacy in treating experimental rats with PF through inhibiting the over expression of serum and SGK 1 .